Attached files
| file | filename |
|---|---|
| 10-Q - FORM 10-Q - THERAGENICS CORP | t73222_10q.htm |
| EX-2.1 - EXHIBIT 2.1 - THERAGENICS CORP | ex2-1.htm |
| EX-31.2 - EXHIBIT 31.2 - THERAGENICS CORP | ex31-2.htm |
| EXCEL - IDEA: XBRL DOCUMENT - THERAGENICS CORP | Financial_Report.xls |
| EX-32.2 - EXHIBIT 32.2 - THERAGENICS CORP | ex32-2.htm |
| EX-31.1 - EXHIBIT 31.1 - THERAGENICS CORP | ex31-1.htm |
CERTIFICATION PURSUANT TO
SECTION 1350, CHAPTER 63 OF TITLE 18, UNITED STATES CODE,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Theragenics Corporation, (the “Company”) on Form 10-Q for the period ended March 31, 2012 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, M. Christine Jacobs, President and Chief Executive Officer, certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
|
(1)
|
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|
|
|
(2)
|
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of the dates and for the periods referred to in the Report.
|
|
Date: May 14, 2012
|
By:
|
/s/ M. Christine Jacobs
|
|
M. Christine Jacobs
|
||
|
Chief Executive Officer
|
A signed original of this written statement required by Section 906 has been provided to Theragenics Corporation and will be retained by Theragenics Corporation and furnished to the Securities and Exchange Commission or its staff upon request.